ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176503 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176503; 2) Community: the network communities that were significantly associated with the response to NSC 176503; 3) Molecule: the relationships between components within communities and NSC 176503; 4) MDR: the compounds that were significantly associated with the NSC 176503.

NSC Compound Enrichment Correlation
NSC 294526 Null 0.00313644776247638 0.39143378
NSC 363812 Tetraplatin 0.00313644776247638 0.4136628
NSC 373980 Null 0.00313644776247638 0.58611024
NSC 380721 Eremantholide B 0.00313644776247638 0.58101215
NSC 39135 Null 0.00313644776247638 0.4863564
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.00313644776247638 0.49893007
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.00313644776247638 0.64262399
NSC 677256 Null 0.00313644776247638 0.47417225
NSC 685833 7H-Purine, 2,6-dichloro- 7-[2-deoxy-3,5-O-bis(4-methylphenyl)- .beta.-D-ribofuranosyl]- 0.00313644776247638 0.67406552
NSC 691081 Null 0.00313644776247638 0.48181998
Total:176  Current:25    [First] [Prev] [Next] [Last]